• Product NameOzagrel
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityOzagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet, used for the improvement of postoperative cerebrovascular contraction and accompanying cerebral ischaemia.
• Target NameThrombin inhibitor
• CAS No. 82571-53-7
• Calculated MW 228.25
• Formulation C13H12N2O2
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Metabolism system
  SMILES:C1=CC(=CC=C1CN2C=CN=C2)/C=C/C(=O)O
  Pathways:Others
  Receptor:Thromboxane A2 synthetase
  Boling pt:
  Melting pt:
  Solubility:DMSO: 46 mg/mL (201.53 mM)
  Appearance:WhitePowder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Ishitsuka Y, et al. J Pharmacol Sci, 2009, 111(2), 211-215.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting